Picloxydine (Drops) Instructions for Use
Marketing Authorization Holder
Kosmofarm, LLC (Russia)
Manufactured By
Slavic Pharmacy, LLC (Russia)
ATC Code
S01AX16 (Picloxydine)
Active Substance
Picloxydine (Rec.INN registered by WHO)
Dosage Form
| Picloxydine | Eye drops 0.05%: dropper bottle 10 ml |
Dosage Form, Packaging, and Composition
Eye drops as a transparent, colorless or slightly colored solution.
| 1 ml | |
| Picloxydine dihydrochloride | 0.5 mg |
Excipients: dextrose monohydrate, polysorbate 80, hydrochloric acid solution 1M or sodium hydroxide solution 1M, water for injections.
10 ml – polymeric dropper bottles (1) – cardboard packs.
Clinical-Pharmacological Group
Topical antiseptic for use in ophthalmology
Pharmacotherapeutic Group
Antimicrobial agent
Pharmacological Action
An antimicrobial agent for use in ophthalmology, a derivative of biguanides. It has an antiseptic effect.
Picloxydine is active against Staphylococcus aureus, Streptococcus faecalis, Escherichia coli, Eberthella typhosa, Klebsiella pneumoniae, Proteus vulgaris, Shigella dysenteriae, Bacillus subtilis, Chlamydia trachomatis, some viruses and fungi.
Pharmacokinetics
With topical application, the systemic absorption of picloxydine is low.
Indications
Bacterial infections of the anterior segment of the eye, dacryocystitis; prevention of infectious complications in the postoperative period after surgical interventions in the area of the anterior segment of the eye.
ICD codes
| ICD-10 code | Indication |
| H01.0 | Blepharitis |
| H04.3 | Acute and unspecified inflammation of lacrimal passages |
| H04.4 | Chronic inflammation of lacrimal passages |
| H10.2 | Other acute conjunctivitis |
| H10.4 | Chronic conjunctivitis |
| H10.5 | Blepharoconjunctivitis |
| H15.0 | Scleritis |
| H15.1 | Episcleritis |
| H16 | Keratitis |
| H20.0 | Acute and subacute iridocyclitis (anterior uveitis) |
| H20.1 | Chronic iridocyclitis |
| Z29.2 | Other prophylactic chemotherapy (administration of antibiotics for prophylactic purposes) |
| ICD-11 code | Indication |
| 9A01.3 | Infectious blepharitis |
| 9A02.Z | Inflammatory disorders of eyelid, unspecified |
| 9A11.Z | Disorders of the lacrimal passages, unspecified |
| 9A1Z | Diseases of the lacrimal system, unspecified |
| 9A60.4 | Blepharoconjunctivitis |
| 9A60.Z | Conjunctivitis, unspecified |
| 9A71 | Infectious keratitis |
| 9A7Z | Diseases of the cornea, unspecified |
| 9A96.Y | Other specified anterior uveitis |
| 9A96.Z | Anterior uveitis, unspecified |
| 9B50 | Episcleritis |
| 9B51 | Scleritis |
| QC05.Y | Other specified prophylactic measures |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Use topically for ophthalmic infections and postoperative prophylaxis.
Instill one to two drops into the affected eye.
Apply two to six times daily, depending on infection severity.
For postoperative prophylaxis, use for the duration specified by the surgeon.
Administer for a maximum of 10 days unless otherwise directed.
Wash hands thoroughly before use.
Avoid contact between the dropper tip and the eye or any other surface to prevent contamination.
If using other ophthalmic products, maintain an interval of at least 15 minutes between instillations.
After instillation, press a finger on the inner corner of the eye for 2 minutes to minimize systemic absorption.
Do not use for subconjunctival injection or introduction into the anterior chamber of the eye.
Discontinue use and consult a physician if symptoms persist or worsen.
Adverse Reactions
Possible development of allergic reactions, manifested by conjunctival hyperemia.
Contraindications
Hypersensitivity to picloxydine.
Use in Pregnancy and Lactation
Use during pregnancy and breastfeeding is not recommended.
Pediatric Use
Can be used in children from 0 years of age as indicated.
Special Precautions
If other medicinal products in the form of eye drops are used along with picloxydine, it is necessary that the interval between their instillations is at least 15 minutes.
To prevent picloxydine from entering the systemic circulation through the nasal mucosa, it is recommended to press a finger on the inner corner of the eye for 2 minutes after instillation.
Picloxydine must not be used for subconjunctival injections or for introduction into the anterior chamber of the eye.
Effect on the ability to drive vehicles and mechanisms
After application of picloxydine, temporary blurred vision is possible. If such symptoms occur, the patient must wait for complete restoration of visual clarity before driving vehicles or working with mechanisms.
Storage Conditions
Store at 15°C (59°F) to 25°C (77°F). Keep in original packaging, protected from light. Keep out of reach of children.
Dispensing Status
Over-the-Counter
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer